Atypical Lung Findings in COVID-19 Patients
Study reveals unusual lung signs in COVID-19 among patients with Omicron variant.
― 5 min read
Table of Contents
In late 2019, a new virus known as COVID-19 emerged, causing serious health issues such as respiratory failure and pneumonia. This virus, named SARS-CoV-2, is a part of a larger family of coronaviruses that primarily infect the upper respiratory tract. Other viruses in this family include those known for causing severe respiratory diseases, like the Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome.
As the pandemic progressed, new variants of SARS-CoV-2 developed, each varying in how contagious and severe they are. One notable variant, designated "Omicron" by the World Health Organization (WHO) in late 2021, spread rapidly across many countries. Omicron had a higher number of mutations compared to earlier variants, which influenced its behavior in the infected individuals.
Recognizing the Symptoms of COVID-19
Common symptoms of COVID-19 include fever, dry cough, difficulty breathing, sore throat, and fatigue. Some patients also experience symptoms that are less typical, like abdominal pain, vomiting, and diarrhea. Research has shown that a range of unusual or less common symptoms may appear in certain COVID-19 patients.
Diagnosing COVID-19 and Importance of CT Scans
The main test used to confirm a SARS-CoV-2 infection is called the reverse transcription polymerase chain reaction (RT-PCR). However, doctors can also use additional tests, such as imaging techniques like chest CT scans, to check for lung issues. Chest CT scans have proven to be highly effective, with a sensitivity rate of 97%. The results from these scans are essential for monitoring the condition and evaluating treatment options.
CT scans often reveal specific patterns associated with COVID-19, with some common findings being changes in the lungs such as a reversed halo sign and specific patterns resembling paving stones. A variety of other unusual signs have also been identified in COVID-19 patients.
The Study on Atypical Pulmonary Manifestations
In early 2022, a study was conducted in two hospitals in Iran to better understand the presence of unusual lung findings in COVID-19 patients during the Omicron variant period. The study focused on patients who tested positive for COVID-19 through RT-PCR, ensuring they had no prior lung disease or surgery, and were over 18 years old.
A total of 606 patients were examined using chest CT scans, providing crucial information about the presence of atypical signs. This study aimed to highlight the unusual findings that could assist in diagnosing COVID-19 effectively.
Findings from CT Imaging
CT imaging was performed using advanced scanning technology. Each patient's results were independently analyzed by two specialists, carefully looking for any atypical markers. The study defined various atypical signs to be evaluated, which included:
- Isolated upper lobe involvement
- Solitary involvement
- Changes around the blood vessels
- Lobar consolidation
- Tree-in-bud pattern
- Centrilobular nodules
- Pleural effusion
- Pleural thickening
- Pericardial effusion
- Subpleural sparing
- White lung appearance
- Halo sign
- Reverse halo sign
- Target-shaped opacity
- Lymphadenopathy
- Air bubble sign
- Changes in the airways
Patient Demographics and Atypical Findings
The results from the study showed that 55% of the patients were female, and the average age was 56 years. It was notable that a significant number of patients over 60 years old displayed atypical findings on their chest CT scans. Overall, 59% of the patients had at least one unusual sign on their scans.
Among these atypical findings, pleural thickening was the most commonly observed issue, found in 17% of patients. Interestingly, no patients showed signs of cavitation, which refers to the formation of hollow spaces in the lung tissue.
Atypical Findings Based on Sex and Age
The study also delved into how atypical findings varied between men and women. Overall, there were no major differences, but certain findings, such as changes around the blood vessels and the reverse halo sign, were more common in women. In contrast, signs like pleural thickening were more commonly seen in men.
When examining the data based on age groups, the percentages of patients with atypical findings were relatively similar across three groups: those under 40, those aged 40 to 60, and those over 60. However, some specific atypical signs showed significant differences based on age, particularly in older patients.
Importance of Atypical Findings in Diagnosis
Identifying these atypical signs is crucial for accurately diagnosing COVID-19, especially as the virus continues to evolve. Typical findings have been widely discussed and understood since the start of the pandemic, but the less common manifestations deserve more attention as they can cause confusion in diagnosing the disease.
The study found a higher incidence of atypical signs when compared to other research conducted previously. For example, prior studies reported a significantly lower frequency of unusual signs. Various factors, such as the specific variant of the virus, patient characteristics, and how the study was set up, could explain these differences.
Conclusion: The Need for Awareness and Attention
With 59% of patients in the study showing atypical findings on their lung scans, it's clear that these manifestations should not be overlooked. The findings suggest that certain abnormalities, particularly those affecting the pleura, are common in COVID-19 patients.
Looking ahead, increased awareness of these atypical signs may help medical professionals avoid misdiagnoses and provide timely treatments. As the virus continues to change, understanding the full range of possible CT findings is essential for managing COVID-19 effectively.
In summary, this research highlights the importance of recognizing various presentations of COVID-19 in imaging tests, especially in the context of the Omicron variant. Continued investigation into these atypical signs will be crucial for improving patient care and outcomes as the pandemic evolves.
Title: Frequency of Atypical Pulmonary Manifestations of COVID-19 Patients on Chest CTscan: A cross-sectional study
Abstract: BackgroundChest CT examination is significant in COVID-19 diagnosis due to its high sensitivity. Although typical chest CT findings have been discussed thoroughly in the literature throughout the pandemic, we aimed to investigate the prevalence of the atypical conclusions during the start of the Omicron variant insurgency and compare the results to studies conducted before its outbreak. Methods606 confirmed COVID-19 cases were included in this study based on inclusion and exclusion criteria during January and February 2022. Demographic information of patients, including age and sex, was recorded. The computed tomography (CT) examination was carried out using a 100-slice scanner (Philips Brilliance 6 CT Scanner). One radiology attending and one resident evaluated SARS-CoV-2 RT-PCR-positive patients for atypical pulmonary CT findings. The obtained data were evaluated using R software version 4.1.1. Results55% of patients were female, and the median age was 56 (IQR: 42, 69) 59% of patients had atypical findings on their pulmonary CT examination. These findings showed that pleural abnormalities were the most frequent atypical findings, with pleural thickening being the most common (17%). The double halo sign represented the least frequent atypical sign (0.2%). ConclusionAtypical findings were more prevalent in this study than its predecessors, while we acknowledge that other factors, such as study design and patient population, could have impacted it. The presence of atypical signs generally was not correlated with specific demographic groups, while some of these signs were more frequent in some groups.
Authors: Ehsan Ghafouri, S. Borji, P. Isavand, M. Azami
Last Update: 2023-08-02 00:00:00
Language: English
Source URL: https://www.medrxiv.org/content/10.1101/2023.07.28.23293261
Source PDF: https://www.medrxiv.org/content/10.1101/2023.07.28.23293261.full.pdf
Licence: https://creativecommons.org/licenses/by/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to medrxiv for use of its open access interoperability.